首页> Cardiovascular diabetology> Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.

Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.

导出 OA

翻译打印收藏纠错

第一作者： Lauren K,Truby

第一单位： Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, 27710, USA.;Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.

作者： Lauren K,Truby ^[1] ; Jessica A,Regan ^[1] ; Stephanie N,Giamberardino ^[2] ; Olga,Ilkayeva ^[2] ; James,Bain ^[2] ; Christopher B,Newgard ^[2] ; Christopher M,O'Connor ^[3] ; G Michael,Felker ^[4] ; William E,Kraus ^[1] ; Robert W,McGarrah ^[1] ; Svati H,Shah ^[5]

作者单位： Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, 27710, USA.;Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. ^[1] Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, 27710, USA. ^[2] Inova Heart and Vascular Institute, Falls Church, NC, USA. ^[3] Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. ^[4] Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, 27710, USA. svati.shah@duke.edu.;Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. svati.shah@duke.edu.;Precision Genomics Collaboratory, Duke University School of Medicine, Durham, USA. svati.shah@duke.edu. ^[5]

关键词 Diabetes Exercise Heart failure Long chain acylcarnitines